UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 12, 2015
QUINTILES TRANSNATIONAL HOLDINGS INC.
(Exact name of registrant as specified in its charter)
| | | | |
North Carolina | | 001-35907 | | 27-1341991 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| |
4820 Emperor Blvd. Durham, North Carolina | | 27703 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (919) 998-2000
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
On November 12, 2015, Quintiles Transnational Holdings Inc. (the “Company”) entered into a Share Repurchase Agreement (the “Agreement”) with Temasek Life Sciences Private Limited (“Temasek”). Pursuant to the Agreement, on November 13, 2015, the Company will complete the repurchase of 3,000,000 shares of the Company’s common stock, par value $0.01 per share, from Temasek in a private transaction for an aggregate purchase price of approximately $198.7 million. The Company funded this private repurchase transaction with cash on hand. The Agreement was entered into pursuant to the Company’s previously disclosed share repurchase program. Following this repurchase, the Company will have acquired approximately 3.9 million shares since November 2, 2015 in a combination of open market and private transactions and will have approximately $148.6 million remaining under its repurchase authorization.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | |
Date: November 13, 2015 | | | | QUINTILES TRANSNATIONAL HOLDINGS INC. |
| | | | |
| | | | | | By: | | /s/ Kevin K. Gordon |
| | | | | | | | Kevin K. Gordon |
| | | | | | | | Executive Vice President, Chief Operating Officer and Chief Financial Officer |